Ligand validation:8V9Q

A2G: 2-acetamido-2-deoxy-alpha-D-galactopyranose

A2G is a Ligand Of Interest in 8V9Q designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8V9Q_A2G_D_101	53%	36%	0.196	0.958	1.74	0.89	3	-	0	0	100%	0.9333
8V9Q_A2G_H_101	20%	29%	0.214	0.816	1.78	1.21	4	1	3	0	100%	0.9333
8V9Q_A2G_F_101	3%	14%	0.315	0.625	1.83	2.23	5	7	2	0	100%	0.9333
8UI6_A2G_B_1001	45%	66%	0.209	0.944	0.5	0.78	-	1	0	0	100%	0.9333
2A2D_A2G_A_459	99%	14%	0.053	0.991	1.08	2.92	1	6	0	0	100%	1
5T5P_A2G_b_201	99%	29%	0.046	0.982	1.11	1.86	2	3	0	0	100%	0.9333
5T5J_A2G_a_201	99%	43%	0.049	0.983	0.94	1.31	-	2	0	0	100%	0.9333
8PN5_A2G_I_101	99%	31%	0.049	0.98	1.82	1.08	3	1	0	0	100%	0.9333
5XG5_A2G_A_201	98%	41%	0.053	0.977	1.35	1.01	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.